Fig. 5
From: Immune-Related Long Non-coding RNA Constructs a Prognostic Signature of Ovarian Cancer
Chemo-sensitivity assessment by risk assessment signature. The box-plot showed that there were difference expressions of the risk assessment signature in cisplatin (A), paclitaxel (B), AZD.2281 (C), vinblastine (D), camptothecin (E) and docetaxel (F)